HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roger K Cady Selected Research

Sumatriptan (Imigran)

12/2017A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.
12/2017Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.
5/2015AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
1/2015A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
4/2014Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combination.
11/2011Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
9/2011Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
5/2011Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
7/2009Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials.
1/2007Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roger K Cady Research Topics

Disease

47Migraine Disorders (Migraine)
03/2021 - 11/2002
27Headache (Headaches)
12/2017 - 11/2002
17Pain (Aches)
12/2017 - 11/2002
4Epilepsy (Aura)
12/2017 - 01/2007
3Photophobia (Light Sensitivity)
12/2017 - 02/2007
3Nausea
12/2017 - 02/2007
3Hyperacusis (Phonophobia)
12/2017 - 02/2007
3Headache Disorders (Headache Syndromes)
12/2017 - 05/2004
2Secondary Headache Disorders
08/2013 - 11/2009
2Dysmenorrhea (Menstrual Pain)
05/2011 - 07/2009
2Fatigue
02/2009 - 02/2007
2Sleepiness
10/2008 - 02/2007
1Hypersensitivity (Allergy)
03/2021
1Flushing
12/2017
1Neck Pain (Cervicalgia)
12/2017
1Paresthesia (Dysesthesia)
12/2017
1Ganglion Cysts (Ganglion)
04/2015
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
06/2012
1Celiac Disease (Celiac Sprue)
06/2012
1Migraine without Aura (Common Migraine)
04/2012
1Hyperalgesia
03/2009
1Nasopharyngitis
02/2009
1Heartburn (Pyrosis)
02/2009
1Gastroesophageal Reflux (GERD)
02/2009
1Dizziness (Lightheadedness)
10/2008
1Vomiting
02/2007
1Rhinosinusitis
01/2006

Drug/Important Bio-Agent (IBA)

15Tryptamines (Triptans)IBA
12/2017 - 04/2004
12Sumatriptan (Imigran)FDA LinkGeneric
12/2017 - 11/2002
8TabletsIBA
05/2015 - 01/2007
8Pain-FreeIBA
09/2011 - 11/2002
7Pharmaceutical PreparationsIBA
03/2021 - 05/2007
6Topiramate (Topamax)FDA LinkGeneric
02/2014 - 11/2007
5sumatriptan-naproxenFDA Link
04/2014 - 01/2007
5rizatriptan (Maxalt)FDA Link
01/2012 - 05/2009
4Calcitonin Gene-Related PeptideIBA
03/2021 - 01/2006
4Type A Botulinum Toxins (Botox)FDA Link
02/2014 - 02/2010
4almotriptan (Axert)FDA Link
03/2009 - 02/2007
3frovatriptan (Allegro)FDA Link
01/2016 - 11/2009
3SodiumIBA
04/2014 - 01/2007
3Naproxen (Naprosyn)FDA LinkGeneric
04/2014 - 07/2009
2PowdersIBA
05/2015 - 01/2015
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2009 - 02/2009
2Valproic Acid (Depakote)FDA LinkGeneric
02/2009 - 07/2008
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2009 - 01/2007
1eptinezumabIBA
03/2021
1Monoclonal AntibodiesIBA
03/2021
1Peptides (Polypeptides)IBA
01/2019
1AntibodiesIBA
01/2019
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2019
1Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
01/2019
1DFN-02IBA
12/2017
1PlacebosIBA
08/2016
1salicylhydroxamic acid (SHAM)IBA
08/2016
1Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric
04/2015
1LactoseFDA LinkGeneric
01/2015
1preemptIBA
08/2013
1Glutens (Glutelin)IBA
06/2012
1Dosage Forms (Dosage Form)IBA
11/2011
1Analgesics (Analgesic Drugs)IBA
11/2009
1P-430IBA
05/2009
1Ethanol (Ethyl Alcohol)IBA
02/2009
1Prescription DrugsIBA
02/2009
1S-2-O-carbamoyl-1-o-chlorophenyl-ethanolIBA
02/2009
1Anticonvulsants (Antiepileptic Drugs)IBA
02/2009
1eletriptan (Relpax)FDA Link
05/2007
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2007
1butalbitalFDA LinkGeneric
01/2007
1KetorolacIBA
01/2007
1Caffeine (No Doz)FDA LinkGeneric
01/2007
1Codeine (Codeine Phosphate)FDA LinkGeneric
01/2007
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
01/2006
1NeuropeptidesIBA
01/2006
1PseudoephedrineFDA LinkGeneric
01/2006
1Indicators and Reagents (Reagents)IBA
05/2004

Therapy/Procedure

13Therapeutics
04/2012 - 11/2002
4Aftercare (After-Treatment)
11/2007 - 09/2005
1Intravenous Administration
03/2021
1Vagus Nerve Stimulation
08/2016
1Drug Therapy (Chemotherapy)
02/2010
1Injections
11/2009
1Time-to-Treatment
03/2009
1Treatment Delay
11/2002